Vayas360 Announces Agreement for $25 Million Lead Investment From AND Capital Ventures

Proposed Investment Is Expected to Anchor Vayas360’s First Close and Support an Acquisition-Led Personalized Health Platform

Vayas360 today announced that it has entered into an Agreement for a proposed $25 million institutional lead investment from AND Capital Ventures, an AI-native, operator-led private equity and growth capital platform, to support a full-spectrum personalized health platform centered on the individual.

The proposed capital will serve as the institutional lead investment in the first close of Vayas360’s current raise and support the company’s acquisition-led platform strategy. Vayas360 is acquiring a Food Is Medicine Coalition-accredited medically tailored meals operator with established payer relationships and accredited therapeutic programs — the initial operational layer in its broader strategy to assemble an integrated ecosystem spanning diagnostics through practitioner-guided care.

Read More on Fintech : Global Fintech Interview with Rob Young, Managing Director – UK at InDebted

“Clinicians who practice whole-person care have always understood that no single intervention drives lasting outcomes,” said Dr. Joel Evans, Chief Medical Officer of Vayas360. “It takes diagnostics, genomic testing, and microbiome analysis to know where someone is, targeted nutrition and supplementation to support their biology, monitoring to track progress, and coaching to sustain it.”

AND Capital Ventures is an AI-native, operator-led global investment and growth capital platform focused on high-conviction sectors where operational complexity creates durable advantage. It brings an operator-led perspective under Chief Executive Officer Teruel Carrasco and a physician-executive lens through Dr. Denise Brown, General Partner of its Health and Wellness Innovation Fund, who has more than 30 years of clinical and business leadership scaling healthcare organizations.

“Vayas360 reflects exactly the type of platform AND Capital Ventures was built to support: clinically grounded, operationally complex, data-driven, and positioned at the intersection of healthcare, prevention, and longevity,” said Teruel Carrasco, Chief Executive Officer of AND Capital Ventures. “The next generation of health and wellness companies will be integrated platforms, not single-point solutions.”

“What stood out to us about Vayas360 is that the model starts with the individual but does not stop at consumer wellness,” said Dr. Denise Brown, General Partner of AND Capital Ventures’ Health and Wellness Innovation Fund. “It connects clinical insight, nutrition, biometrics, and longitudinal data to support better decisions for patients, providers, employers, and payer partners, particularly around cardiometabolic risk, longevity, and women’s health.”

At the center of the model is Vayaspan, the company’s term for the personalized span of life where energy, metabolic resilience, strength, cognitive clarity, and confidence work together. Vayas360 connects biological data to daily action and is expected, if developed as planned, to generate longitudinal outcomes data at the individual level.

“Someone taking a more active role in their health today is often doing it with disconnected tools,” said Ron Martin, Chief Commercial Officer of Vayas360. “Vayaspan describes what it looks like when those pieces work together for one person.”

Vayas360 serves consumers, patients, practitioners, employers, and payer partners, and its acquisition strategy assembles the operational layers behind that model, beginning with payer-connected clinical nutrition capabilities and established care protocols.

“We chose our lead investor the same way we chose our acquisition. The fit had to be right, and AND Capital was the right fit,” said Snow Le, Chairman and CEO of Vayas360. “AND Capital Ventures brought conviction in healthspan and longevity and an operator-led perspective that matches how we build. We are not building a single product; we are assembling an ecosystem through multiple transactions.”

The post Vayas360 Announces Agreement for $25 Million Lead Investment From AND Capital Ventures appeared first on GlobalFinTechSeries.